Search Results 201-210 of 14751 for anti-TNF drugs

1. New study finds rheumatology prescribing, spending linked to pharmaceutical payments - Mayo Clinic News Network

   Ali Duarte Garcia, M.D.. "Before the 2000s most of the treatments for rheumatic diseases consisted of non-steroidal anti-inflammatory medications, or NSAIDS, ...

2. A Study of the Effectiveness of Methotrexate as Initial Treatment and Maintenance of a Steroid Free Remission in Ulcerative Colitis - Mayo Clinic

   Anti-TNF therapy in the 2 weeks before the week 0 visit; Failure of cyclosporine therapy in the previous 6 months prior to screening visit; Serum albumin ...

3. Adrian T. Ting, Ph.D. - Mayo Clinic Faculty Profiles

   This has posed a challenge to its potential use in anti-tumor therapy. Furthermore, TNF -mediated cytotoxicity presumably evolved as an antimicrobial mechanism, ...

4. Pediatric MSC-AFP Sub-study for Crohn's Fistula - Mayo Clinic

   Competent and able to provide written informed consent (and assent where appropriate). Must have failed standard medical therapy including anti-TNF agents.

5. Anti-Inhibitor Coagulant Complex (Intravenous Route) Precautions - Mayo Clinic

   Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines ...

6. Stem Cell Coated Fistula Plug in Patients With Crohn's RVF - Mayo Clinic

   ... therapy; Concurrent therapies with corticosteroids, 5-ASA drugs, thiopurines, MTX, antibiotics, and anti-TNF therapy are permitted. All patients should have ...

7. Cellular Responses to DNA Damage Induced by Topoisomerase Poisons - Anticancer Drug Action Laboratory - Mayo Clinic Research

   This enzyme is also the target of the anti-cancer drugs irinotecan, topotecan, MM398, PLX038 and CBX-12, along with a growing number of antibody-drug conjugates ...

8. Targeted Drug Therapy Clinical Trials - Mayo Clinic Research

   The primary purpose of this study is to assess the anti-tumor activity of LGX818/MEK162 in combination with targeted agents after progression on LGX818/MEK162 ...

9. Rubella Virus Vaccine, Live (Subcutaneous Route) Before Using - Mayo Clinic

   Adalimumab; Anifrolumab-fnia; Ansuvimab-zykl ... Etanercept; Etrasimod; Everolimus; Fidanacogene ... drugs may be the best treatment for you. If both ...

10. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

    anti-TNF alpha agents) =< 2 weeks prior to randomization, or anticipation of need for systemic immunosuppressive medication during study treatment, with the ...